Technical analysis of AquaBounty Technologies, Inc. (AQB): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption.
Price Performance
| 1 month | -19.57% |
| 3 months | +18.09% |
| Year-to-date | +19.35% |
| 1 year | -2.63% |
| 3 years | -77.62% |
| 5 years | -98.74% |
52-Week Range
| 52-week High | $2.95 |
| 52-week Low | $0.77 |
| Avg Volume (90d) | 360K |
Technical Indicators
| SMA 50 | $1.13 |
| SMA 200 | $1.00 |
| 30-day Volatility (annualised) | 95.6% |
| Price vs SMA 50 | -1.4% |
| Price vs SMA 200 | +11.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.30 | |
| 2025-11 | $1.01 | -22.3% |
| 2025-12 | $0.93 | -7.9% |
| 2026-01 | $0.91 | -2.2% |
| 2026-02 | $0.97 | +6.6% |
| 2026-03 | $0.87 | -10.8% |
| 2026-04 | $0.94 | +8.4% |
| 2026-05 | $1.04 | +10.9% |
| 2026-06 | $1.07 | +2.9% |
| 2026-07 | $0.91 | -15.4% |
| 2026-08 | $1.27 | +40.2% |
| 2026-09 | $1.11 | -12.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $0.03 | $1M |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $144M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
Price
| Price | $1.11 |
| Market Cap | $6M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.03 |
| EV / EBITDA | -3.27 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 4.26 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -53.47 |